Matinas BioPharma Files 8-K on Current Events
Ticker: MTNB · Form: 8-K · Filed: Feb 20, 2024 · CIK: 1582554
| Field | Detail |
|---|---|
| Company | Matinas Biopharma Holdings, Inc. (MTNB) |
| Form Type | 8-K |
| Filed Date | Feb 20, 2024 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 5 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, corporate-governance
TL;DR
**Matinas BioPharma just filed a routine 8-K, nothing major, just standard disclosure stuff.**
AI Summary
Matinas BioPharma Holdings, Inc. filed an 8-K on February 20, 2024, to report a current event. The filing indicates the company's business address is 1545 Route 206 South, Suite 302, Bedminster, New Jersey 07921, and its telephone number is (908) 484-8805. This 8-K includes information under Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
Why It Matters
This filing provides basic administrative and reporting information, confirming Matinas BioPharma's compliance with SEC disclosure requirements.
Risk Assessment
Risk Level: low — The filing is a standard administrative 8-K with no specific financial or operational disclosures that would indicate increased risk.
Key Players & Entities
- Matinas BioPharma Holdings, Inc. (company) — registrant
- February 20, 2024 (date) — date of report
- 1545 Route 206 South, Suite 302, Bedminster, New Jersey 07921 (location) — business address
- (908) 484-8805 (phone_number) — registrant's telephone number
- Delaware (location) — state of incorporation
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant as specified in its charter is MATINAS BIOPHARMA HOLDINGS, INC.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is February 20, 2024.
What is the business address of Matinas BioPharma Holdings, Inc.?
The business address is 1545 Route 206 South, Suite 302, Bedminster, New Jersey 07921.
What is the registrant's telephone number?
The registrant's telephone number is (908) 484-8805.
What items of information are included in this 8-K filing?
This 8-K filing includes information under Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
Filing Stats: 1,366 words · 5 min read · ~5 pages · Grade level 14.6 · Accepted 2024-02-20 07:35:32
Filing Documents
- form8-k.htm (8-K) — 53KB
- ex99-1.htm (EX-99.1) — 31KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-24-007115.txt ( ) — 270KB
- mtnb-20240220.xsd (EX-101.SCH) — 3KB
- mtnb-20240220_lab.xml (EX-101.LAB) — 33KB
- mtnb-20240220_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MATINAS BIOPHARMA HOLDINGS, INC. Dated: February 20, 2024 By: /s/ Jerome D. Jabbour Name: Jerome D. Jabbour Title: Chief Executive Officer -4-